Literature DB >> 7754001

Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain.

D P DiPaolo1, R A Zimmerman, L B Rorke, E H Zackai, L T Bilaniuk, A T Yachnis.   

Abstract

PURPOSE: To investigate a correlation between pathologic and radiologic findings with regard to the characteristic high-signal-intensity foci seen on long repetition time (TR) magnetic resonance (MR) images of the brain in patients with neurofibromatosis type 1 (NF-1).
MATERIALS AND METHODS: Three girls with NF-1 and abnormal hyperintensities on long TR images of the brain underwent pathologic examination at autopsy.
RESULTS: Two 10-year-old girls had classic, focal hyperintensities in the internal capsules and globus pallidus regions, which have been associated with NF-1. The third patient, a neonate, had diffuse hyperintensity of the supratentorial and infratentorial white matter on T2-weighted MR images. Findings at histopathologic examination revealed spongiotic change in the tissue sections that correspond to the high-signal-intensity foci demonstrated on T2-weighted images.
CONCLUSION: Hyperintense foci seen on T2-weighted MR images appear to correspond to pathologic findings of areas of vacuolar or spongiotic change. The resultant fluid-filled vacuoles explain the occurrence of high signal intensity demonstrated on T2-weighted images.

Entities:  

Mesh:

Year:  1995        PMID: 7754001     DOI: 10.1148/radiology.195.3.7754001

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  58 in total

Review 1.  MR imaging of midbrain pathologies.

Authors:  E Hattingen; S Blasel; M Nichtweiss; F E Zanella; S Weidauer
Journal:  Clin Neuroradiol       Date:  2010-06-09       Impact factor: 3.649

Review 2.  Neuroimaging of phakomatoses: overview and advances.

Authors:  Gilbert Vézina
Journal:  Pediatr Radiol       Date:  2015-09-07

Review 3.  An update on the central nervous system manifestations of neurofibromatosis type 1.

Authors:  J Stephen Nix; Jaishri Blakeley; Fausto J Rodriguez
Journal:  Acta Neuropathol       Date:  2019-04-08       Impact factor: 17.088

Review 4.  Neural phenotypes of common and rare genetic variants.

Authors:  Carrie E Bearden; David C Glahn; Agatha D Lee; Ming-Chang Chiang; Theo G M van Erp; Tyrone D Cannon; Allan L Reiss; Arthur W Toga; Paul M Thompson
Journal:  Biol Psychol       Date:  2008-02-23       Impact factor: 3.251

5.  Corpus callosum morphology and microstructure assessed using structural MR imaging and diffusion tensor imaging: initial findings in adults with neurofibromatosis type 1.

Authors:  E L Wignall; P D Griffiths; N G Papadakis; I D Wilkinson; L I Wallis; O Bandmann; P E E Cowell; N Hoggard
Journal:  AJNR Am J Neuroradiol       Date:  2010-03-18       Impact factor: 3.825

6.  Psychological aspects of von Recklinghausen neurofibromatosis (NF1)

Authors:  K N North
Journal:  J Med Genet       Date:  1996-09       Impact factor: 6.318

7.  Diffusion tensor imaging of neurofibromatosis bright objects in children with neurofibromatosis type 1.

Authors:  Gulhan Ertan; Elcin Zan; David M Yousem; Can Ceritoglu; Aylin Tekes; Andrea Poretti; Thierry A G M Huisman
Journal:  Neuroradiol J       Date:  2014-09-25

8.  Olfactory bulb enlargement in neurofibromatosis type 1: report of a novel finding.

Authors:  Alessandra D'Amico; Martina Di Stasi; Lorenzo Ugga; Teresa Perillo; Claudia Santoro; Daniela Melis
Journal:  Childs Nerv Syst       Date:  2021-02-10       Impact factor: 1.475

9.  MR imaging of the corpus callosum in pediatric patients with neurofibromatosis type 1.

Authors:  E C Dubovsky; T N Booth; G Vezina; C A Samango-Sprouse; K M Palmer; C O Brasseux
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

10.  Magnetization transfer ratio and volumetric analysis of the brain in macrocephalic patients with neurofibromatosis type 1.

Authors:  Persefoni N Margariti; Konstantinos Blekas; Frosso G Katzioti; Anastasia K Zikou; Meropi Tzoufi; Maria I Argyropoulou
Journal:  Eur Radiol       Date:  2006-05-30       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.